OPK Opko Health Inc
Price (delayed)
$1.53
Market cap
$1.03B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.08
Enterprise value
$1.09B
Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and
Highlights
Opko Health's quick ratio has soared by 159% YoY and by 18% from the previous quarter
The net income has soared by 72% year-on-year and by 60% since the previous quarter
The gross profit has contracted by 31% YoY but it has grown by 22% from the previous quarter
Opko Health's gross margin has increased by 22% from the previous quarter but it has decreased by 17% YoY
The debt has soared by 61% YoY
The company's revenue fell by 17% YoY
Key stats
What are the main financial stats of OPK
Market
Valuations
Earnings
Shares outstanding
671.55M
Market cap
$1.03B
Enterprise value
$1.09B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.76
Price to sales (P/S)
1.49
EV/EBIT
29.43
EV/EBITDA
8.07
EV/Sales
1.53
Revenue
$713.14M
Gross profit
$218.51M
Operating income
-$152.07M
Net income
-$53.22M
EBIT
$37.09M
EBITDA
$135.26M
Free cash flow
-$208.26M
Per share
Balance sheet
Liquidity
EPS
-$0.08
EPS diluted
-$0.08
Free cash flow per share
-$0.3
Book value per share
$2
Revenue per share
$1.03
TBVPS
$1.52
Total assets
$2.2B
Total liabilities
$834.76M
Debt
$495.7M
Equity
$1.37B
Working capital
$468.99M
Debt to equity
0.36
Current ratio
3.43
Quick ratio
2.85
Net debt/EBITDA
0.47
Margins
Efficiency
Dividend
EBITDA margin
19%
Gross margin
30.6%
Net margin
-7.5%
Operating margin
-21.3%
Return on assets
-2.5%
Return on equity
-3.9%
Return on invested capital
4.2%
Return on capital employed
1.8%
Return on sales
5.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPK stock price
How has the Opko Health stock price performed over time
Intraday
6.99%
1 week
7.75%
1 month
-15%
1 year
22.4%
YTD
4.08%
QTD
-7.83%
Financial performance
How have Opko Health's revenue and profit performed over time
Revenue
$713.14M
Gross profit
$218.51M
Operating income
-$152.07M
Net income
-$53.22M
Gross margin
30.6%
Net margin
-7.5%
The net income has soared by 72% year-on-year and by 60% since the previous quarter
The net margin has soared by 66% YoY and by 60% QoQ
The gross profit has contracted by 31% YoY but it has grown by 22% from the previous quarter
Opko Health's gross margin has increased by 22% from the previous quarter but it has decreased by 17% YoY
Growth
What is Opko Health's growth rate over time
Valuation
What is Opko Health stock price valuation
P/E
N/A
P/B
0.76
P/S
1.49
EV/EBIT
29.43
EV/EBITDA
8.07
EV/Sales
1.53
Opko Health's EPS has soared by 68% YoY and by 56% from the previous quarter
The P/B is 35% below the 5-year quarterly average of 1.1
Opko Health's equity has decreased by 2.7% QoQ
The company's revenue fell by 17% YoY
The P/S is 7% below the 5-year quarterly average of 1.5 but 7% above the last 4 quarters average of 1.3
Efficiency
How efficient is Opko Health business performance
Opko Health's ROS has soared by 146% from the previous quarter and by 126% YoY
OPK's ROIC has soared by 143% since the previous quarter and by 117% year-on-year
The ROA has soared by 72% YoY and by 62% from the previous quarter
The ROE has soared by 70% YoY and by 60% QoQ
Dividends
What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPK.
Financial health
How did Opko Health financials performed over time
The company's total assets is 164% higher than its total liabilities
Opko Health's quick ratio has soared by 159% YoY and by 18% from the previous quarter
Opko Health's current ratio has soared by 121% YoY and by 15% from the previous quarter
The debt is 64% lower than the equity
The debt to equity has soared by 64% year-on-year
The debt has soared by 61% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.